Trimtech Therapeutics
biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases
Trimtech Therapeutics has raised €41M across 2 funding rounds from 10 investors, most recently a Seed round in Jun 2026. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKtrimtechtherapeutics.com ↗
Total raised
€41M
€41,285,202
Funding rounds
2
Investors
10
distinct backers
Active since
2025-03
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDTrimtech Therapeutics — funding by year — interactive chart.
Data table
| Trimtech Therapeutics — funding by year | |
|---|---|
| 2025 | €29M |
| 2026 | €12M |
Signals
High confidenceRaise-next likelihood26
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Young (<3y)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-23 | Seed | €12M | BGF,Johnson & Johnson Innovation – JJDC | View deal → |
| 2025-03-05 | Seed | €29M | Cambridge Enterprise,Cambridge Innovation Capital,Dementia Discovery Fund,Eli lilly and company,M Ventures,MP Healthcare Venture Management+2 more | View deal → |